LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth
company, is pleased to announce its appointment of Bobby Jindal,
the 55th Governor of the State of Louisiana, to its board of
directors.
Mr. Jindal was elected as the nation’s youngest governor in 2007
and spent two terms as Louisiana’s chief executive officer to
rebuild and diversify the state’s economy and financial footing in
the aftermath of Hurricanes Katrina and Rita. Prior to serving as
Governor, Mr. Jindal held positions as the head of the Louisiana
Department of Health and Hospitals, President of the University of
Louisiana System, Assistant Secretary of the U.S. Department of
Health and Human Services, U.S. Congressman, and Executive Director
of the National Bipartisan Commission on the Future of
Medicare.
Beyond the public sector, Jindal advised senior management of
Fortune 500 firms as an associate at McKinsey & Co. Mr. Jindal
currently serves as Operating Adviser at Ares Private Equity Group.
Jindal has served on numerous boards, and currently serves on the
boards of Hornbeck Offshore Services and U.S. Heart and Vascular.
He previously served on the boards of WellCare, Granicus, and
Cotton Holdings.
“We are pleased to announce Bobby's appointment to our Board of
Directors,” said Justin Schreiber, Chairman and CEO of LifeMD.
“Bobby brings to LifeMD a deep background in healthcare and is
passionate about the role virtual care can play in driving access
to high quality and affordable care. I’m looking forward to working
with Bobby to enhance and scale our current virtual care offerings
and identify new opportunities for LifeMD’s telehealth
platform.”
“We are excited to expand LifeMD’s Board with another
world-class Director with deep insights in healthcare policy and
impact,” added Naveen Bhatia, an independent director of LifeMD.
“Given Bobby’s experience in advancing Louisiana’s public health
with innovative healthcare policies, and his operational expertise
in the private sector, our Board welcomes a leader of his caliber
joining and contributing to our continued goal of transforming the
face of American healthcare and maximizing shareholder value.”
“I am excited about the opportunity for telehealth to empower
consumers by reducing the cost of healthcare, increasing access,
and improving patient outcomes. Technology driven virtual care
platforms, such as what LifeMD is building, will dramatically
reshape how countless Americans access and benefit from
healthcare,” said Bobby Jindal. “LifeMD has built a technology
platform and medical infrastructure that have already served
hundreds of thousands of patients. I’m looking forward to being a
part of the next chapter of LifeMD’s growth and transformation and
helping to position the company as a leader in patient-centered
healthcare.”
About LifeMD
LifeMD is a 50-state direct-to-patient telehealth company with a
portfolio of brands that offer virtual primary care, diagnostics,
and specialized treatment for men’s and women’s health, allergy
& asthma, and dermatological conditions. By leveraging our
proprietary technology platform, affiliated 50-state medical group,
and nationwide mail-order pharmacy network, LifeMD is increasing
access to top-notch healthcare that is affordable to anyone. To
learn more, go to LifeMD.com.
Cautionary Note Regarding Forward Looking
Statements
This news release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended;
Section 21E of the Securities Exchange Act of 1934, as amended; and
the safe harbor provision of the U.S. Private Securities Litigation
Reform Act of 1995. Forward-looking statements contained in this
news release may be identified by the use of words such as:
“believe,” “expect,” “anticipate,” “project,” “should,” “plan,”
“will,” “may,” “intend,” “estimate,” predict,” “continue,” and
“potential,” or, in each case, their negative or other variations
or comparable terminology referencing future periods. Examples of
forward-looking statements include, but are not limited to,
statements regarding our financial outlook and guidance, short and
long-term business performance and operations, future revenues and
earnings, regulatory developments, legal events or outcomes,
ability to comply with complex and evolving regulations, market
conditions and trends, new or expanded products and offerings,
growth strategies, underlying assumptions, and the effects of any
of the foregoing on our future results of operations or financial
condition.
Forward-looking statements are not historical facts and are not
assurances of future performance. Rather, these statements are
based on our current expectations, beliefs, and assumptions
regarding future plans and strategies, projections, anticipated and
unanticipated events and trends, the economy, and other future
conditions, including the impact of any of the aforementioned on
our future business. As forward-looking statements relate to the
future, they are subject to inherent risk, uncertainties, and
changes in circumstances and assumptions that are difficult to
predict, including some of which are out of our control.
Consequently, our actual results, performance, and financial
condition may differ materially from those indicated in the
forward-looking statements. These risks and uncertainties include,
but are not limited to, “Risk Factors” identified in our filings
with the Securities and Exchange Commission, including, but not
limited to, our most recently filed Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and any amendments thereto. Even if
our actual results, performance, or financial condition are
consistent with forward-looking statements contained in such
filings, they may not be indicative of our actual results,
performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based
on information currently available to us as of the date on which
this release is made. We undertake no obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise, except as may be required
under applicable law or regulation.
Company Contact LifeMD, Inc. Marc Benathen,
CFOEmail Contact
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From May 2023 to Jun 2023
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From Jun 2022 to Jun 2023